The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation

International Journal of Obesity

Volumn 22, Issue 5, 1998, Pages 477-484

  Hashimoto, M ^a   Akishita, M ^a   Eto, M ^a   Kozaki, K ^a   Ako, J ^a   Sugimoto, N ^a   Yoshizumi, M ^a   Toba, K ^a   Ouchi, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endothelium; Endothelium derived factors; Obesity; Vasodilatation

Indexed keywords

FATTY ACID; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYOCOL SPRAY; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; BODY FAT; BODY MASS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPEREMIA; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS FAT; SUBLINGUAL DRUG ADMINISTRATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION; VISCERA;

EID: 0031947613     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800620     Document Type: Article

References (40)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
2. Van Itallie TB. Obesity: adverse effects on health and longevity. Am J Clin Nutr 1979; 32(Suppl): 2723-2733.
3. Mann GV. The influence of obesity on health. N Engl J Med 1974; 291: 178-185, 226-232.
4. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. Circulation 1996; 93: 1372-1379.
5. Vague J. The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
6. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982; 36: 172-177.
7. Terry JG, Hinson WH, Evans GW, Schreiner PJ, Hagaman AP, Crouse JR III. Evaluation of magnetic resonance imaging for quantification of intraabdominal fat in human beings by spin-echo and inversion-recovery protocols. Am J Clin Nutr 1995; 62: 297-301.
8. Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, Matsushima Y, Murayama H, Ohshima H, Shinomiya M, Shirai K, Saito Y, Yoshida S, Saisho H, Ohto M. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med 1993; 95: 309-314.
9. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.
10. Kanai H, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Nagai Y, Fujioka S, Tokunaga K, Tarui S. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension 1990; 16: 484-490.
11. Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, Gustafson AB, Kissebah AH. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 1989; 110: 867-872.
12. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthropometric classification of fat distribution shown by computed tomography. BMJ 1985; 290: 1692-1694.
13. Rocchini AP, Moorehead C, Katch V, Key J, Finta KM. Forearm resistance, vessel abnormalities and insulin resistance in obese adolescents. Hypertension 1992; 19: 615-620.
14. Mangoni AA, Giannattasio C, Brunani A, Failla M, Colombo M, Bolla G, Cavagnini F, Grassi G, Mancia G. Radial artery compliance in young, obese, normotensive subjects. Hypertension 1995; 26: 984-988.
15. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/Insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610.
16. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 1990; 16: 349-356.
17. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
18. Report of a foundation of health and its maintenance study group in the Ministry of Health and Welfare of Japan. Health and Degree of Obesity 1994; 1: 1-26.
19. Noma A, Okabe H, Netsu-Nakayama K, Ueno Y, Shinohara H. Improved method for simultaneous determination of cholesterol in high- and low-density lipoproteins. Clin Chem 1979; 25: 1480-1481.
20. Shimizu S, Tani Y, Yamada H, Tabata M, Murachi T. Enzymatic determination of serum-free fatty acids: a colorimetric method. Anal Biochem 1980; 107: 193-198.
21. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Moller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
22. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest 1994; 93: 50-55.
23. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Sagara Y, Taketani Y, Orimo H, Ouchi Y. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995; 92: 3431-3435.
24. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand U. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of computerized analyzing system. Clin Physiol 1991; 11: 565-577.
25. Reneman RS, Van Merode T, Hick P, Muytjens MM, Hoeks APG. Age-related changes in carotid wall properties in man. Ultrasound Med Biol 1986; 12: 465-471.
26. Salonen R, Salonen JT. Determinants of carotid intima-media thickness; a population based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229: 225-231.
27. Wendelhag I, Wiklund O, Wikstrand J. Arterial wall thickness in hypercholesterolemia. Arterioscler Thromb 1992; 12: 70 77.
28. Landin K, Krotkiewski M, Smith U. Importance of obesity for metabolic abnormalities associated with an abdominal fat distribution. Metabolism 1989; 38: 572-576.
29. Rissanen J, Hudson R, Ross R. Visceral adiposity, androgens, and plasma lipids in obese men. Metabolism 1994; 43: 1318-1323.
30. Mäkimattila S, Virkamäki A, Groop PH, Cockcroft J. Utriainen T, Fagerudd J, Yki-Järvinen H. Chronic hyperglycaemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996; 94: 1276-1282.
31. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996; 16: 368-374.
32. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995; 92: 320-326.
33. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO III. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95: 1747-1755.
34. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, Hirakawa Y, Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 1996; 79: 331-335.
35. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-1319.
36. Hotamisligil GS, Arner P, Caro JF, Atkinson RL. Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
37. Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengbom L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044-1048.
38. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nature Med 1996; 2: 800-803.
39. Blann AD, Bushell D, Davies A, Faragher EB, Miller JP, McCollum CN. von Willebrand factor, the endothelium and obesity. Int J Obes 1993; 17: 723-725.
40. Yoshizumi M, Perrela MA, Burnett Jr JC, Lee M-E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993; 73: 205-209.